188 related articles for article (PubMed ID: 19742337)
21. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
22. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
23. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
24. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
Solomon MJ; McLeod RS
CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
[TBL] [Abstract][Full Text] [Related]
25. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
[TBL] [Abstract][Full Text] [Related]
26. [Primary evaluation of a mass screening program for colorectal tumor in China].
Huang YQ; Cai SR; Zhang SZ; Li QL; Ma XY; He YF; Zhou XH; Zheng S
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):601-4. PubMed ID: 22041562
[TBL] [Abstract][Full Text] [Related]
27. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
[TBL] [Abstract][Full Text] [Related]
28. Detecting colorectal cancer with a large scale fecal occult blood testing program.
Gregorio DI; Lolachi P; Hansen H
Public Health Rep; 1992; 107(3):331-5. PubMed ID: 1594743
[TBL] [Abstract][Full Text] [Related]
29. [Colorectal cancer screening programs in the population at average risk in the European Union and Spain].
Grau J; Serradesanferm A; Polbach S; García-Basteiro AL; Trilla A; Castells A
Gastroenterol Hepatol; 2010 Feb; 33(2):111-8. PubMed ID: 19523716
[TBL] [Abstract][Full Text] [Related]
30. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
Green T; Richardson A; Parry S
N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
[TBL] [Abstract][Full Text] [Related]
31. Are there gender differences in colorectal cancer test use prevalence and correlates?
McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
[TBL] [Abstract][Full Text] [Related]
32. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
Slusser SO; Liberski SM; McGarrity TJ
Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
[TBL] [Abstract][Full Text] [Related]
33. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
Loss J; Eichhorn C; Nagel E
Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
36. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
Strul H; Elyakim R; Halpern Z; Arber N
Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
38. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
39. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
40. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
